ICAN Clinical InvestigationICAN Clinical Investigation, an expert clinical investigation platform dedicated to cardiometabolic diseasesLocated in the IE3M (Institute of Endocrinology, Metabolic Diseases and Internal Medicine) in the heart of the Pitié-Salpêtrière Hospital site, ICAN Clinical Investigation is a clinical investigation platform dedicated to biomedical research. As experts in cardiometabolic diseases, the ICAN Clinical Investigation teams support academic or industrial sponsors in setting up their clinical projects and contribute to the smooth running of clinical trials, from the feasibility stage and the selection of the center to the closing of the project.
Thanks to its unique location in in Europe’s largest public hospitalICAN Clinical Investigation is the key contact for coordinating the various departments within the Pitié-Salpêtrière Hospital and the Department of Clinical Research and Innovation (DRCI) to carry out innovative academic and industrial clinical research projects.Download the brochureICAN Clinical Investigation in a few figuresdoctors in the network
of the IHU-ICANongoing clinical studiesinnovative care pathways
put in placepatients included in
clinical studies and cohorts
in 2020patients received a
innovative therapeutic moleculeThe ICAN Clinical Investigation platform, expert at all stages of your studyFeasibility study and sizing of the research project
- Support for sizing the project: number of patients, number and types of examinations, assessment of human resources needs
- Legal support in the contracting of studies thanks to the expertise of the Legal and Valorization Pole of the IHU-ICAN
- Assistance in setting up a project by the Scientific Operations Department of the IHU ICAN
Setting up the studyOptimization of recruitment
- Telephone pre-screening, verification of inclusion and exclusion criteria
- Very targeted screening “consultations, HDJ, complete hospitalizations, cohorts…”
- Assistance to investigators during inclusion and follow-up visit
A dedicated patient and sampling circuit
- Management and organization of the patient circuit between the different departments
- Preparation of the roadmap and source documents
- Samples: monitoring the quality of samples, storage
- Immediate proximity to the Bio ICAN Biological Resource Center (ISO 9001 and NFS 96-900 certifications)
Data quality and responsiveness
- Completion of the eCRF within the required deadlines
- Serious adverse event (SAE) reporting within regulatory deadlines
- Investigator Workbooks Update
Reporting throughout the study
- Continuity of inclusions and project monitoring thanks to back-up clinical study technicians
- Reporting throughout the study to the sponsor
- Budget tracking and invoicing
Analysis of budgetary needs
- Accurate cost assessment
- Negotiation of counterparties
Closing of the study
- Closure and archiving of documents at the end of the study
- Query management before database freezes
Invoicing of projects and investigator fees
- Follow-up of counterparties intended for project leaders
- Flexibility to use counterparties with a dedicated IHU ICAN investigator account
Our research facilities
- Electrocardiograph
- Impedance meter
- DEXA bone densitometer (to assess metabolic health and bone density)
- FibroScan® (liver elasticity measurement)
- Cardiac ultrasound
- Liver ultrasound
- Cardiometabolic MRI
The team
- 1 clinical platform manager
- 1 assistant clinical platform manager
- 2 research physicians
- 1 clinical research nurse
- 15 clinical research associates and clinical study technicians
- 1 medical electroradiology technician
Jeanne HaidarHead of the clinical platformj.haidar@ihuican.org
01 84 82 77 80ICAN Clinical Investigation
E3M Institute
recherche.clinique@ihuican.orgPitié-Salpêtrière Hospital
47-83 Hospital Boulevard
75013 ParisOur main partnersFounders
- AP-HP/DRCI
- Inserm
- Sorbonne University
Academic partners
- NFSA
- French Society of Cardiology
- European Society of Cardiology
Contract Research Organization (CRO)
- Covance
- Health Sciences
- icon
- IQVIA
- Medpace
- Parexel
- PDP
- PRA
- Syneos Health
Hospital partnerships
- Annecy
- Grenoble
- Lille
- Lyons
- Marseilles
- Nancy
- Nantes
- Poitiers
- Saint Etienne
Pharmaceutical laboratoriesAbbott, Allergan, AMGEN, AstraZeneca, Boehringer Ingelheim, Celgene, Enanta Pharmaceuticals, ENYO Pharma, Galecto Biotech, Galmed Pharmaceuticals, Genetech, GENFIT, Intercept Pharmaceuticals, Inventiva, Ionis Pharmaceuticals, Lilly, Madrigal Pharmaceuticals, MSD, NGM Biopharmaceuticals, Novartis, Novo Nordisk, Regeneron Pharmaceuticals, Roche, Sanofi,Medical device companies
- Biotronik
- Boston Scientific
- Medtronic
The strengths of ICAN InvestigationCustom madeA single point of contact who supervises your project from feasibility to completion of the studyexpertiseSolid expertise thanks to highly qualified clinical study technicians in the various medical disciplinesNetworkNetworking thanks to close links with the various departments of Pitié-Salpêtrière and the Clinical Research and Innovation Department (DRCI)AgilityAdaptation of project resources according to needs and inclusion constraints (respect of deadlines, etc.)FlexibilityCounterparties are negotiated as fairly as possible and ICAN offers great flexibility in their uses (HR, equipment, congresses, etc.)
